Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Polaprezinc Granules

Approval Number

国药准字H20140134

Company海思科制药（眉山）有限公司

Registration Date

June 14, 2024

Drug Information

Generic Name

聚普瑞锌颗粒

Brand Name

邦可复

Dosage Form

颗粒剂

Strength

75mg

Drug Type

化学药品

Registration Date

June 14, 2024

Company Information

Applicant Company

Company Name海思科制药（眉山）有限公司

Company Address

四川省眉山市经济开发区东区顺江大道南段53号

Manufacturing Company

Company Name海思科制药（眉山）有限公司

Company Address

四川省眉山市经济开发区东区顺江大道南段53号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy